Anthera Pharmaceuticals Inc Stock Nasdaq
Equities
US03674U3005
Biotechnology & Medical Research
Financials (USD)
Sales 2016 | 0.14 | Sales 2017 | - | Capitalization | 22.85M |
---|---|---|---|---|---|
Net income 2016 | -55M | Net income 2017 | -26M | EV / Sales 2016 | 44,069,434 x |
Net cash position 2016 | 20.84M | Net cash position 2017 | 2.2M | EV / Sales 2017 | - |
P/E ratio 2016 |
-0.4
x | P/E ratio 2017 |
-0.58
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 100% |
1st Jan change | Capi. | |
---|---|---|
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |